Roger E, Lagarce F, Garcion E, Benoit JP. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine. 2010;5:287–306.

Article  PubMed  CAS  Google Scholar 

Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504–26.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557–70.

Article  PubMed  CAS  Google Scholar 

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

Article  PubMed  Google Scholar 

Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid FB. EAU guidelines on prostate cancer. Eur Urol. 2008;53:68–80.

Article  PubMed  Google Scholar 

Budavari S. The Merck index. 13th ed. United States: Whitehouse Station; 2003.

Google Scholar 

Sternal R, Nugara N. Analytical profiles of drug substances and excipients. California: Academic; 2001.

Google Scholar 

Salgado HRN, Menezes M, Storti MPB. Determination of flutamide in tablets by high-performance liquid chromatography. Acta Farm Bonaer. 2005;24:246–9.

CAS  Google Scholar 

Zuo Z, Tam YK, Diakur J, Wiebe LI. Hydroxypropyl-b-cyclodextrin flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in rat. J Pharm Pharmaceut Sci. 2002;5:292–8.

CAS  Google Scholar 

Par®tt K. Martindale: complete drug reference. London: Pharmaceutical; 1999.

Google Scholar 

Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs- a review. J Pharm Anal. 2014;4:159–65.

Article  PubMed  CAS  Google Scholar 

Chen XJ, Wang T, Lu MM. Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes. Int J Nanomed Nanosurg. 2014;9:2655–64.

Google Scholar 

Müller RH, Radtke M, Wissing SA. Solid nanoparticle (SLN) and nanostructured lipid carrier (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:131–55.

Article  Google Scholar 

Moghddam SM, Ahad A, Aqil M, Imam SS, Sultana Y. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using box-behnken design approach. Artif Cells Nanomed Biotechnol. 2016;45:617–24.

Article  PubMed  Google Scholar 

Khan S, Baboota S, Ali J, Narang RS, Narang JK. Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs. Int J Pharm Investig. 2015;5:182–91.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on sln and nlc for topical clotrimazole delivery. Int J Pharm. 2004;278:71–7.

Article  PubMed  CAS  Google Scholar 

Jenning V, Thunemann AF, Gohla SH. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm. 2000;199:167–77.

Article  PubMed  CAS  Google Scholar 

Rizwanullah M, Amin S, Ahmad J. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. J Drug Target. 2017;25:58–74.

Article  PubMed  CAS  Google Scholar 

Elsheikh MA, Elnaggar YSR, Gohar EY, Abdallah OY. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomed. 2012;7:3787–802.

CAS  Google Scholar 

Thakkar H, Nangesh J, Parmar M, Patel D. Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system. J Pharm Bioallied Sci. 2011;3:442–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shishu R, Kamalpreet S. Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS PharmSciTech. 2009;10:559–65.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thapa C, Ahad A, Aqil M, Imam S, Sultana Y. Formulation and optimization of nanostructured lipid carriers to enhance oral bioavailability of telmisartan using Box- Behnken design. J Drug Deliv Sci Tech. 2018;44:431–9.

Article  CAS  Google Scholar 

Singh A, Neupane YR. NLCs for oral bioavailability enhancement of exemestane: formulation, design, in vitro, ex vivo and in vivo studies. J Pharm Sci. 2019;108:3382–95.

Article  PubMed  CAS  Google Scholar 

Joshi M, Pathak S, Sharma S, Patravale V. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. Int J Pharm. 2008;364:119–26.

Article  PubMed  CAS  Google Scholar 

Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 2010;74:474–82.

Article  PubMed  CAS  Google Scholar 

Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 2008;346:124–32.

Article  PubMed  CAS  Google Scholar 

Jawahar N, Hingarh KP, Arun R. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers. Int J Biol Macromol. 2018;110:269–75.

Article  PubMed  CAS  Google Scholar 

Youshia J, Kamel AO, Shamy A, Mansour S. Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide. Int J Nanomed. 2012;7:2483–96.

CAS  Google Scholar 

Wu C, Ji P, Yu T, Liu Y, Jiang J, Xu J. Naringenin loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Dev Ther. 2016;10:911–25.

Article  Google Scholar 

Sethuraman N, Shanmuganathan S, Sandhya K, Anbarasan B. Design, development and characterization of nanostructured lipid carrier for topical delivery of aceclofenac. Indian J Pharm Educ Res. 2018;52:581–6.

Article  CAS  Google Scholar 

Patil-Gadhe A, Pokharkar V. Montelukast-loaded nanostructured lipid carriers: part I oral bioavailability improvement. Eur J Pharm Biopharm. 2014;88:160–8.

Article  PubMed  CAS  Google Scholar 

Kumbhar DD, Pokharkar VB. Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: physicochemical investigations. Colloids Surf Physicochem Eng Aspects. 2013;416:32–42.

Article  Google Scholar 

Agrawal Y, Petkar KC, Sawant KK. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 2010;401:93–102.

Article  PubMed  CAS  Google Scholar 

Chalikwar SS, Belgamwar VS, Talele VR. Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces. 2012;97:109–16.

Article  PubMed  CAS  Google Scholar 

Lu S, Yu PP, Zhang SS. Enhanced dissolution and oral bioavailability of lurasidone hydrochloride nanosuspensions prepared by anti-solvent precipitation- ultrasonication method. RSC Adv. 2016;6:49052–9.

Article  CAS  Google Scholar 

Natrajan J, Baskaran M, Humtsoe CL. Enhanced brain targeting efficacy of olanzapine through solid lipid nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45:364–71.